U.S. Electronic Equipment and Components Stock News

AGI (NYSE:AGBK) has filed a substantial Shelf Registration tied to an Employee Stock Ownership Plan for a large block of Class A common shares. The filing outlines a framework for issuing ESOP related shares over time, which can influence the company’s capital structure and employee ownership levels. AGI, trading at $7.39, has had mixed recent performance, with the stock up 4.2% over the past week and 9.5% over the past month, while showing a 31.3% decline year to date. The new ESOP related...

Fastly, Inc. previously reported first-quarter 2026 results with revenue rising to US$173.02 million from US$144.47 million a year earlier, while narrowing its net loss to US$20.52 million and cutting basic loss per share from US$0.27 to US$0.13. The quarter highlighted especially strong momentum in higher-margin security and compute products, which delivered record contributions and underpinned Fastly’s decision to raise full-year 2026 revenue and profit guidance. We’ll now examine how...

Rivian Automotive (RIVN) is back in focus after recent trading left the stock showing a loss of about 2% over the past day and weaker performance across the past week. See our latest analysis for Rivian Automotive. That weak 1-day share price return of about 2% comes on top of a 7-day share price return of about 13% and a year-to-date share price return of about a 27% decline. The 1-year total shareholder return of about 4% hints that recent momentum has been fading rather than building. If...

Oppenheimer Holdings Inc. reported first-quarter 2026 results, with revenue rising to US$445.1 million from US$367.83 million a year earlier, but swinging from net income of US$30.66 million to a net loss of US$20.58 million, and moving from basic earnings per share of US$2.93 to a basic loss of US$1.93. Despite this shift to a loss, the company also announced a quarterly dividend of US$0.20 per share payable on May 29, 2026, indicating continued cash returns to shareholders even as...

American Bitcoin stock moves after recent trading swing American Bitcoin (ABTC) has drawn fresh attention after a recent trading swing, with the stock closing at US$1.16 and carrying a market value of about US$1.33b in the US listed Bitcoin mining space. See our latest analysis for American Bitcoin. The recent 7.2% one-day share price decline comes after a 33.1% 30-day share price return, while the year-to-date share price return of 34.83% suggests momentum has been fading over a longer...

In early May 2026, Snap reported Q1 results that slightly exceeded analyst expectations, with revenue up 12.1% year on year to US$1.53 billion and a GAAP loss of US$0.05 per share, while also filing a US$520.31 million shelf registration for 85,577,681 Class A shares linked to employee stock plans. A key development was the launch of AI Sponsored Snaps, highlighted by Experian’s April 28 announcement that it is integrating its financial education agent into Snapchat’s conversational ad...

In late April 2026, O-I Glass, Inc. reported first-quarter 2026 results showing sales of US$1,540 million, down from US$1,567 million a year earlier, and a wider net loss of US$73 million versus US$16 million, with basic and diluted loss per share from continuing operations both at US$0.48 compared to US$0.10 previously. This sharp increase in quarterly loss, despite only a modest sales decline, raises questions about cost pressures and profitability trends across O-I Glass's...

Kimco Realty reported past first-quarter 2026 results showing year-over-year growth, with revenue rising to US$558.02 million and net income to US$164.9 million, while also declaring quarterly common and preferred dividends. Alongside these results, management raised full-year 2026 net income guidance per diluted share, signaling increased confidence in the company’s earnings outlook and cash flow visibility. Next, we’ll examine how Kimco’s higher full-year net income guidance influences its...

ImmunityBio (IBRX) is under close watch after an FDA warning letter on allegedly misleading promotional claims for Anktiva and a series of class action lawsuits, even as the company reports recent revenue and global approval figures. See our latest analysis for ImmunityBio. After touching a 1 day share price return of negative 7.4% following the FDA warning letter and class action headlines, ImmunityBio still sits at US$7.76 with a year to date share price return of 284.16% and a 1 year total...

Context and recent stock performance Booking Holdings (BKNG) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and past year. This recent stretch contrasts with the longer term, where Booking Holdings shows positive total returns over the past 3 and 5 years. As a result, some investors are reassessing how current pricing lines up with the company’s fundamentals. See our latest analysis for...

Wondering if Fox at around US$62.69 is priced for opportunity or already reflects the story? This piece walks through the key numbers to help you frame that question clearly. The stock has seen mixed recent returns, with a 1.3% decline over the last week, a 5.1% gain over the last 30 days, a 15.0% decline year to date and a 25.5% return over the last year, alongside longer term returns of 112.3% over three years and 72.6% over five years. Recent market interest has been shaped by ongoing...

Array Digital Infrastructure (AD) has reported full year 2025 results with fourth quarter revenue of US$60.3 million and basic EPS of US$0.48, alongside trailing twelve month EPS of US$1.97 on revenue of US$163.0 million and net income from ongoing operations of US$169.7 million. Over recent periods the company has seen quarterly revenue move between US$25.7 million and US$60.3 million, while basic EPS has ranged from a loss of US$1.12 per share to a profit of US$1.26 per share. This gives...

1stdibs.Com (DIBS) closed out FY 2025 with Q4 revenue of US$23.0 million and a basic EPS loss of US$0.03, while trailing 12-month revenue was US$89.6 million and EPS a loss of US$0.38. Over the past six reported quarters, revenue has moved between US$21.2 million and US$22.8 million per quarter, while basic EPS losses have ranged from US$0.15 to US$0.03. This has left investors focused on how much further margins can tighten or stabilize from here. See our full analysis for 1stdibs.Com. With...

Recent price moves and performance snapshot Integra LifeSciences Holdings (IART) has drawn attention after a sharp move, with the stock up about 29% over the past week and roughly 45% over the past month from its recent levels. See our latest analysis for Integra LifeSciences Holdings. That surge sits against a mixed backdrop, with a 90 day share price return of 20.43% and a 3 year total shareholder return decline of 72.66%, suggesting recent momentum is rebuilding after a tough stretch. If...

In early May 2026, Coherent Corp. reported third-quarter fiscal 2026 sales of US$1,805.64 million and net income of US$191.40 million, both up sharply from a year earlier, while also confirming strong AI data center and communications demand and a multiyear, multi‑billion‑dollar collaboration with NVIDIA. Alongside this, Coherent is rapidly expanding its 6‑inch indium phosphide wafer capacity and simplifying its capital structure, positioning its photonics business more squarely around...

If you are wondering whether American States Water at around US$76.84 is priced fairly or offering value, it helps to step back and look at what the recent share performance and fundamentals are signaling. Over the short term the stock is up 2.1% over the last week and is roughly flat over the past month with a 0.1% decline, while year to date it is up 6.3% and the 1 year return sits at a 1.8% decline. These moves come as investors continue to react to company specific developments and the...

Halozyme Therapeutics (NasdaqGS:HALO) has entered a new global collaboration with GSK to apply its ENHANZE technology to subcutaneous delivery of multiple oncology products. The agreement includes development of subcutaneous formulations for antibody drug conjugates, expanding ENHANZE into a new class of cancer therapies. The collaboration introduces additional potential royalty streams tied to future use of ENHANZE across GSK’s oncology portfolio. Halozyme Therapeutics, trading at $65.19,...

Oculis Holding secured a formal Special Protocol Assessment from the FDA for its pivotal Phase 3 PIONEER-1 trial of Privosegtor in optic neuritis. The FDA agreement confirms that the PIONEER-1 trial design is adequate to support a potential future NDA submission. In parallel, new findings from the DME AWARE study support further development of OCS-01 eye drops for diabetic macular edema. These updates arrive with NasdaqGM:OCS trading at $31.09, with the stock up 13.1% over the past week and...

RPM International (RPM) drew fresh attention after reporting third quarter fiscal 2026 earnings and sales that exceeded expectations, alongside guidance regarding sales and adjusted EBIT. See our latest analysis for RPM International. The share price has eased back recently, with a 1 month share price return of 4.84% but a 90 day share price return decline of 13.30%, while the 1 year total shareholder return decline of 6.79% contrasts with a 3 year total shareholder return of 32.76%. This...

Investors may be wondering if Phibro Animal Health at around US$43.16 is still offering value after a strong run, or if the easy gains are behind it. The stock has pulled back 18.8% over the last week and 22.5% over the last month, yet it still shows a 15.7% gain year to date and a 96.6% return over the past year. These sharp moves are drawing attention back to what is already priced into Phibro Animal Health and how much of its story is reflected in the current share price. Ongoing interest...

Recent performance puts Apple Hospitality REIT in focus Apple Hospitality REIT (APLE) has drawn fresh attention after a one-month return of about 19% and a gain of roughly 14% over the past three months, prompting investors to reassess the hotel-focused REIT’s recent momentum. See our latest analysis for Apple Hospitality REIT. At a share price of $13.89, Apple Hospitality REIT’s recent 19.43% 1 month share price return and 15.17% year to date share price return contrast with a steadier 1...

Zai Lab (NasdaqGM:ZLAB) reported new clinical data from its global oncology and immunology pipeline, including intracranial response data for zoci in small cell lung cancer. The company is preparing to launch KarXT in China for schizophrenia in the next quarter. Management highlighted these pipeline and launch updates while also flagging near term revenue pressure. Zai Lab focuses on developing and commercializing medicines in oncology and immunology, as well as central nervous system...

Salesforce (CRM) is back in focus after a flurry of AI-centered announcements, including the launch of Agentforce Operations and Merck Animal Health’s decision to deploy Agentforce Life Sciences across its global customer engagement. See our latest analysis for Salesforce. Despite the flurry of AI product launches and partnerships, including Merck Animal Health adopting Agentforce Life Sciences, Salesforce’s recent price action tells a mixed story, with a 1-day share price return of 2.84% and...

NASB Financial (NASB) has put up a clean set of Q2 2026 numbers, with revenue of US$24.2 million and EPS of US$1.30 anchoring the latest report. The company has seen revenue move from US$19.9 million and EPS of US$0.80 in Q2 2025 to US$24.2 million and EPS of US$1.30 in Q2 2026, while trailing twelve month EPS sits at US$4.52 on revenue of US$92.3 million. For investors, the key takeaway is that profitability and margins sit firmly at the center of this update, setting the tone for how the...